These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4345237)

  • 1. Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.
    Carlsson A; Persson T; Roos BE; Wålinder J
    J Neural Transm; 1972; 33(2):83-90. PubMed ID: 4345237
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.
    Carlsson A; Roos BE; Wålinder J; Skott A
    J Neural Transm; 1973; 34(2):125-32. PubMed ID: 4146641
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
    Wålinder J; Skott A; Carlsson A; Roos BE
    Arch Gen Psychiatry; 1976 Apr; 33(4):501-5. PubMed ID: 779704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 6. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting response to phenothiazines: the right drug for the right patient.
    Galbrecht CR; Klett CJ
    J Nerv Ment Dis; 1968 Aug; 147(2):173-83. PubMed ID: 5677325
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 11. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 13. Triiodothyronine and phenothiazines in schizophrenia.
    Wolpert A; Yaryura-Tobias JA; White L; Merlis S
    Dis Nerv Syst; 1969 Jul; 30(7):487-9. PubMed ID: 5810556
    [No Abstract]   [Full Text] [Related]  

  • 14. [The contribution of drug research to the understanding of schizophrenia].
    Carlsson VA
    Wien Med Wochenschr; 1975 May; 125(21):308-17. PubMed ID: 3029
    [No Abstract]   [Full Text] [Related]  

  • 15. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of thioridazine and chlorpromazine on the ECG and serum potassium level--ECG of the glucose load in 40 cases].
    Kuang RY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):297-9, 319. PubMed ID: 3234162
    [No Abstract]   [Full Text] [Related]  

  • 17. Gradual reduction of neuroleptic drugs among chronic schizophrenics. A double-blind controlled study.
    Lonowski DJ; Sterling FE; Kennedy JC
    Acta Psychiatr Scand; 1978 Feb; 57(2):97-102. PubMed ID: 345749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic concepts based on treatment.
    Brodsky CM
    Psychosomatics; 1971; 12(1):30-5. PubMed ID: 5545625
    [No Abstract]   [Full Text] [Related]  

  • 20. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L; Zalewski K
    Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.